Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.1149 per EA under NDC 24689093306. Its NADAC has been published 199 times since Mar 3, 2021.
Strength
30 mg/1
Manufacturer
Apnar Pharma LPNDC
24689093306
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696On Market Since
6/17/2024
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 199 times since Mar 3, 2021, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.2408 (May 12, 2021) |
| All-time low | $0.1098 (Mar 18, 2026) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.1606 |
| Average price | $0.1623 |
| Largest weekly change | +21.6% (Oct 19, 2022) |
| Weeks tracked | 199 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Apnar Pharma LP, is $0.1149 per EA (NDC 24689093306), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 50.5%. It has been tracked across 199 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.1098 (Mar 18, 2026) to a high of $0.2408 (May 12, 2021), with a median of $0.1606 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUSPIRONE HCL 30 MG TABLET, is $0.1117 per EA — about 3% below BUSPIRONE HCL 30 MG TABLET.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 24689093306) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.
Related Drugs
Same classification